Expressing support for the designation of June 1, 2026, through June 7, 2026, as "Hidradenitis Suppurativa Awareness Week".
- Bill Number
- H.Res. 1331
- Origin Chamber
- House
- Congress
- 119th Congress, Session 2
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2026-06-02: Referred to the House Committee on Energy and Commerce.
- Last Updated
- 2026-06-25T19:17:21Z
AI-Generated Summary
Purpose This resolution expresses congressional support for designating June 1–7, 2026, as “Hidradenitis Suppurativa Awareness Week” to raise public and professional awareness of hidradenitis suppurativa (HS), a chronic inflammatory skin condition.
Key Provisions
- Recognizes that HS affects approximately 3.3 million people in the United States and causes painful nodules, abscesses, skin tunnels, and scarring.
- Notes associated challenges including pain, drainage, odor, itching, psychological distress, and one of the highest suicide rates among skin diseases.
- Highlights issues of delayed diagnosis (75 percent of cases identified after age 25), limited approved treatments (only three FDA-approved biologics), and the need for more research on causes, biomarkers, and therapies.
- Supports the awareness week designation and calls for increased education, improved screening and diagnosis, biomedical research, faster treatment development, expanded access to care, and policies that enhance quality of life for patients and caregivers.
Significant Changes to Existing Law This is a non-binding House resolution that does not amend any statutes or create new legal requirements. It introduces no changes to existing federal law.
Potential Impacts
- Citizens: May increase public understanding of HS, encourage earlier medical attention, and reduce stigma for affected individuals and families.
- Government agencies: Could indirectly influence federal health research priorities or public health messaging through the Department of Health and Human Services or related programs, though no direct mandates are created.
- International relations: No identified effects.
Main Stakeholders Affected
- Individuals living with HS and their caregivers.
- Dermatologists, primary care providers, and other health professionals.
- Biomedical researchers and pharmaceutical developers.
- Patient advocacy organizations focused on skin diseases and rare conditions.
Notable Legal, Constitutional, or Political Implications As a simple resolution of support, it carries no enforceable legal authority and raises no constitutional questions. It reflects a symbolic legislative effort to promote health awareness without altering regulatory frameworks or allocating funds.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (1)
Recent Actions
- 2026-06-02: Referred to the House Committee on Energy and Commerce.
- 2026-06-02: Submitted in House
Bill Versions
- Expressing support for the designation of June 1, 2026, through June 7, 2026, as "Hidradenitis Suppurativa Awareness Week". — issued 2026-06-02 — PDF (3 pages)